FMR1 and fragile X syndrome: Alternatively, Lie et al. utilized a modified CRISPR/Cas9 system to restore Fmr1 expression in fragile X syndrome-induced pluripotent stem cells (iPSCs) via epigenetic modification, subsequently restoring the neurophysiological properties and wild-type phenotype of derived neurons even after engraftment into mouse brains [261].